NASDAQ · Healthcare
$241.85
▲ +$12.92(+5.64%)10:58 AM ET - vs previous closeiQuote as of Sep 17, 2026, 10:58 AM EDT
Realtime NASDAQ quote as of Sep 17, 2026, 10:58 AM EDT.
Market data source
Evidence
84/100
Strong evidence
Session
+5.64%
vs 228.93 prior close
52-week range
99%
of the 88–243.15 range
Consensus target
-16.2%
to 202.65 consensus
TECHi stance
Balanced watch
Model confidence 61/100 · 64/76 inputs
Chart
Latest 1D session
1Y · daily bars · USD · Live $241.85 · 255 pts
Live checkTrade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Investor playbook
The current snapshot gives bulls more to work with, but the watch list still controls timing.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Trend support
+55.5%Current price is above the 200-day average.
Cash yield
2.6%$931.00M free-cash-flow base.
Where the dashboard says the thesis can break or get crowded.
Premium multiple
44.91Trailing P/E is high enough that earnings misses can matter fast.
Catalysts and positioning checks that are not duplicate live-pulse metrics.
Latest catalyst
BenzingaThis Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
Upcoming events
ILMN reports on Oct 28, 2026 during the AMC session.
Countdown
41 days out
As of Sep 17, 2026, 10:58 AM EDT, Illumina Inc. (ILMN) traded at $241.85, a +5.64% move versus the prior close, ranging between $232.99 and $243.15 intraday, and on volume of 838.45K shares. The stock has traded between $88.00 and $243.15 over the past 52 weeks, carries a market capitalization of $36.35B, and trades at 44.91x trailing earnings. Sell-side analysts rate ILMN Buy across 28 ratings and carry an average price target of $202.65 (-16.21% implied versus the last quote). ILMN's record close stands at $540.63, set on Feb 12, 2021.
Buy analyst tone. Latest catalyst: This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday (Benzinga).
| Price / sales | 8.09 |
| Price / book | 12.81 |
| EPS (TTM) | $5.36 |
| Beta (5Y) | 1.47 |
Benchmark context
Compare against the broad market.
Help · FAQ
2 answers covering latest price.
TECHi displays provider-supplied values only when the corresponding field is present.
TECHi.com